University Clinical Hospital of Santiago

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

Head of the Paediatrics Department of the Hospital Clínico Universitario de Santiago. Coordinator of the WHO Collaborating Centre for Vaccine Safety in Santiago de Compostela and member of the WHO-Europe Vaccine Advisory Committee.

Head of the Immunology Department at the Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), Servicio Gallego de Salud (SERGAS)

Contents related to this centre
dog

An analysis of the gut microbiota of children growing up on farms or with pets shows that early establishment of anaerobic commensal bacteria is associated with lower rates of allergy later in life. The study, which used data from 65 children aged between three days and 18 months, is published in the journal PLOS ONE

vaccine

Antimicrobial resistance caused around 5 million deaths worldwide in 2019. The use of vaccines has the potential to reduce these deaths - 515,000 fewer deaths per year - according to a report published by the WHO. The work focused on 24 pathogens and 44 vaccines, licensed by regulatory agencies, in clinical development or in development. By counting existing vaccines alone, antibiotic use could be reduced by 142 million daily doses per year.  

sarampión

Toledo and Alicante are suffering the first outbreaks of measles recorded in Spain since the pandemic, El País reported today. In total, 15 cases have been confirmed since 1 January, of which seven are imported and eight autochthonous.

Nobel

The Karolinska Institute has awarded the Nobel Prize in Medicine or Physiology to Katalin Karikó and Drew Weissman for their groundbreaking discoveries, which have radically changed our understanding of how mRNA interacts with our immune system, and made it possible to develop vaccines at unprecedented speed during the covid-19 pandemic.

Hipra

The European Medicines Agency (EMA) has licensed Hipra's vaccine - currently called Bimervax - against SARS-CoV-2 as a booster in people aged 16 years and older who have previously been vaccinated with mRNA vaccines. The EMA began the ongoing evaluation of the vaccine, which was expected to be approved in the middle of last year, on 29 March 2022.

S_pyogenes

In recent weeks, the UK Health Safety Agency has detected an unusual increase in infections with Streptococcus pyogenes bacteria. At least 13 children under the age of 15 have died from this pathogen, which is responsible for mild infections but also for more serious conditions such as invasive disease. The Spanish Society of Paediatric Infectious Diseases has reported that there have been some deaths in Spain - the Community of Madrid has reported two deaths - and is analysing whether there has been an unusual increase in cases. 
 

Vacunas

During Pfizer's appearance before the European Parliament this week, a company executive responded to the question of whether "Pfizer's vaccine was tested to stop transmission of the virus (SARS-CoV-2) before going to market" by saying "no".

vacuna_Moderna

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved an updated version of the covid-19 vaccine manufactured by Moderna that also targets the omicron variant. It is intended to serve as a booster dose for adults.

Vacunas

Según datos de la OMS y UNICEF, 25 millones de niños no han recibido sus vacunas contra la difteria, el tétanos y la tosferina (DTP) a nivel global. Se trata de la mayor caída continuada en cobertura vacunal en casi treinta años.

Vacuna

In a press release published this week, Moderna has shared the first data on its new bivalent adapted vaccine against Omicron.